Literature DB >> 19252889

[Severe delirium in withdrawal from chronic gamma-hydroxybutyric acid consumption].

G Proest1, T Zschernack, M Stelzig, B Steinacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19252889     DOI： 10.1007/s00115-009-2673-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  6 in total

1.  Adverse events, including death, associated with the use of 1,4-butanediol.

Authors:  D L Zvosec; S W Smith; J R McCutcheon; J Spillane; B J Hall; E A Peacock
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  [Agitation and gamma-hydroxybutyrate].

Authors:  M Hardmeier; M Eichhorn; G Stoppe
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

Review 3.  [Gamma-hydroxybutyrate--a neurotransmitter, medicine, and drug].

Authors:  G Trendelenburg; A Ströhle
Journal:  Nervenarzt       Date:  2005-07       Impact factor: 1.214

Review 4.  The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

Authors:  M Maitre
Journal:  Prog Neurobiol       Date:  1997-02       Impact factor: 11.685

5.  Gamma-hydroxybutyrate withdrawal syndrome.

Authors:  J E Dyer; B Roth; B A Hyma
Journal:  Ann Emerg Med       Date:  2001-02       Impact factor: 5.721

6.  [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)].

Authors:  P X Iten; A Oestreich; R Lips; M Brabetz
Journal:  Schweiz Med Wochenschr       Date:  2000-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.